INTRAOCULAR LYMPHOMA
Clinical trials for INTRAOCULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAOCULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for INTRAOCULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered T-Cells take on tough lymphoma in early trial
Disease control OngoingThis phase I trial tests a new approach for patients with high-risk or recurrent non-Hodgkin lymphoma. After a stem cell transplant, participants receive a single infusion of their own genetically modified T-cells designed to recognize and attack cancer cells. The study aims to f…
Matched conditions: INTRAOCULAR LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New strategy aims to tame common virus after stem cell transplants
Disease control OngoingThis study tests a modified plan to prevent and treat cytomegalovirus (CMV) infection in people with blood cancers who have had a donor stem cell transplant. CMV is a common virus that can cause serious problems after transplant. The study involves 153 participants and looks at w…
Matched conditions: INTRAOCULAR LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Singapore eye study aims to uncover patterns in inflammatory eye diseases
Knowledge-focused OngoingThis study reviews medical records of 200 people in Singapore with inflammatory eye diseases like uveitis and scleritis. Researchers want to understand who gets these conditions, what treatments they receive, and how they do over time. No new treatments are being tested—this is p…
Matched conditions: INTRAOCULAR LYMPHOMA
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:36 UTC